Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › LINGO-1 antagonists and uses for treatment of demyelinating disorders

LINGO-1 antagonists and uses for treatment of demyelinating disorders

US Patent 10435467 · Granted Oct 8, 2019

Estimated economic value: $181,372,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

S1P modulating agents2021
SIP modulating agents2019
S1P modulating agents2018
ATX modulating agents2018
Compounds that are S1P modulating agents and/or ATX modulating agents2018
S1P modulating agents2017
LINGO-2 antagonists for treatment of conditions involving motor neurons2017
Compositions comprising antibodies to LINGO or fragments thereof2017
Cognitive composite parameters and uses thereof for evaluating multiple sclerosi2017
ATX modulating agents2017
Compounds that are S1P modulating agents and/or ATX modulating agents2017
ATX modulating agents2016